CLDX vs NTLA: stock comparison and AI forecast
Celldex Therapeutics, Inc. (CLDX) and Intellia Therapeutics, Inc. (NTLA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CLDX Celldex Therapeutics, Inc.
- Market Cap
- $2.22B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
NTLA Intellia Therapeutics, Inc.
- Market Cap
- $1.56B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CLDX is 1.4 times larger than NTLA by market capitalization ($2.22B against $1.56B).
- CLDX turns 25127.0% of its revenue into net income, against -805.8% for NTLA.
- NTLA carries 0.47 times debt per unit of equity, against 0.11 times for CLDX.
- Both companies share the SEC industry classification In Vitro & In Vivo Diagnostic Substances.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CLDX | NTLA |
|---|---|---|
| Market Cap | $2.22B | $1.56B |
| P/B Ratio | 3.42x | 2.54x |
| EPS | $-5.11 | $-2.52 |
| Book Value/Share | $8.27 | $4.38 |
| Revenue/Share | $-0.02 | $0.38 |
| FCF/Share | $-3.31 | $-2.56 |
Profitability & Margins
| Metric | CLDX | NTLA |
|---|---|---|
| ROE | -47.6% | -69.5% |
| ROA | -42.8% | -47.2% |
| ROIC | -50.6% | -52.8% |
| Operating Margin | 27192.1% | -821.2% |
| Net Margin | 25127.0% | -805.8% |
| EBT Margin | 24866.1% | -821.2% |
Financial Health
| Metric | CLDX | NTLA |
|---|---|---|
| Current Ratio | 10.97x | 6.31x |
| D/E Ratio | 0.11x | 0.47x |
| Financial Leverage | 1.11x | 1.47x |
| Interest Coverage | -260.2x | -200.2x |
| Working Capital | $603M | $426M |
Cash Flow
| Metric | CLDX | NTLA |
|---|---|---|
| Operating Cash Flow | -$252M | -$355M |
| Free Cash Flow | -$260M | -$358M |
| Capital Spending | -$8M | -$3M |
| FCF/Sales | 21117.0% | -677.1% |
| CapEx/Sales | -631.4% | 5.5% |
Operational Efficiency
| Metric | CLDX | NTLA |
|---|---|---|
| Asset Turnover | 0.00x | 0.06x |
| Receivables Turnover | – | 7.0x |
| Fixed Assets Turnover | -0.1x | 3.8x |
| Days Sales Outstanding | – | 52 days |
Income Statement
| Metric | CLDX | NTLA |
|---|---|---|
| Total Revenue | -$1M | $53M |
| Operating Income | -$334M | -$434M |
| Net Income | -$309M | -$426M |
| R&D Expense | $283M | $335M |
Dividend & Shareholder Information
| Metric | CLDX | NTLA |
|---|---|---|
| Shares Outstanding | 79M | 140M |
CLDX vs NTLA: stock comparison and AI forecast
Which is bigger, CLDX or NTLA?
CLDX is 1.4 times larger than NTLA by market capitalization ($2.22B against $1.56B).
Which one does Intratio's AI model rank higher, CLDX or NTLA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.